In the era of sentinel lymph node biopsy (SLNB). the axillary management concept that 1-2 positive sentinel lymph node (SLN) could safely omit axillary lymph node dissection (ALND) are gradually being accepted by more and more patients. The omission of ALND is safe with no difference in regional recurrence in early breast cancer patients with limited SLN involvement. With the effectiv... https://www.soiebiologique.com/limited-price-Test-Evaluation-Command-ACU-Patch-Foliage-Green-flash-choice/